Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

DURECT Corp (NASDAQ:DRRX)

2.10
Delayed Data
As of Aug 28
 +0.08 / +3.96%
Today’s Change
0.68
Today|||52-Week Range
3.42
+166.09%
Year-to-Date
No recent news for DURECT Corp.

Today’s Trading

Previous close2.02
Today’s open2.01
Day’s range1.96 - 2.10
Volume244,882
Average volume (3 months)922,173
Market cap$253.0M
Dividend yield--
Data as of 3:59pm ET, 08/28/2015

Growth & Valuation

Earnings growth (last year)+4.76%
Earnings growth (this year)0.00%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+26.59%
P/E ratioNM
Price/Sales4.54
Price/Book12.90

Competitors

 Today’s
change
Today’s
% change
LPCNLipocine Inc+0.48+3.59%
TRVNTrevena Inc+0.06+1.00%
GALEGalena Biopharma Inc+0.01+0.67%
TKAITokai Pharmaceutical...+0.36+3.18%
Data as of 4:14pm ET, 08/28/2015

Financials

Next reporting dateNovember 2, 2015
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$19.4M
Annual profit (last year)-$22.1M
Net profit margin-113.96%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Scientific Officer
Felix Theeuwes
President, Chief Executive Officer &
Director
James E. Brown
Corporate headquarters
Cupertino, California

Forecasts

Partner Offers